SCHEMBL3786946

SCHEMBL3786946

Nc1ccccc1-c1cccc(N)c1Oc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.52
L3MBTL1 Q9Y468 2/20 0.52
HSD17B10 Q99714 1/20 0.45
BCAT2 O15382 1/20 0.44
MAOB P27338 1/20 0.44
MAOA P21397 1/20 0.43
LTA4H P09960 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 4/20 0.40
MAPT P10636 3/20 0.40
MEN1 O00255 3/20 0.40
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
IDO1 P14902 1/20 0.39
KDM4E B2RXH2 1/20 0.38
GLA P06280 1/20 0.38
NCOA1 Q15788 1/20 0.38
NCOA3 Q9Y6Q9 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3786852 0.86 ALDH1A1 (0.54) ALDH1A1L3MBTL1HSD17B10MAOBMAOA
SCHEMBL30822034 0.86 ALDH1A1 (0.54) ALDH1A1L3MBTL1HSD17B10MAOBMAOA
SCHEMBL7776603 0.85 LTA4H (0.52) ALDH1A1BCAT2MAOBMAOALTA4H
SCHEMBL5745573 0.83 ALDH1A1 (0.45) ALDH1A1L3MBTL1HSD17B10MAOBMAOA
SCHEMBL6681919 0.83 ALDH1A1 (0.46) ALDH1A1L3MBTL1HSD17B10MAOBMAOA
SCHEMBL7544988 0.83 BRD4 (0.43) ALDH1A1MAOBMAOAKMT2AMAPT
SCHEMBL3806719 0.82 NCOA1 (0.53) ALDH1A1HSD17B10MAOBMAOALTA4H
SCHEMBL3785402 0.79 MAOB (0.53) ALDH1A1HSD17B10MAOBMAOAKMT2A
SCHEMBL25135313 0.78 NCOA1 (0.62) ALDH1A1L3MBTL1HSD17B10MAOBMAOA
SCHEMBL7046966 0.78 MEN1 (0.37) ALDH1A1HSD17B10BCAT2MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885L3MBTL1 3838/4885HSD17B10 1100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.